EUS-RFA for Unresectable Pancreatic Ductal Adenocarcinoma

NACompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

December 20, 2018

Primary Completion Date

August 16, 2021

Study Completion Date

August 16, 2021

Conditions
Pancreatic Adenocarcinoma Non-resectable
Interventions
PROCEDURE

Endoscopic ultrasound guided radiofrequency ablation

Endoscopic ultrasound guided radiofrequency ablation (EUS-RFA) will be done in 3 different sessions with 2 weeks interval between each session on Day 1, Day 15 and Day 30. Each session will involve multiple applications of EUS-RFA (up to 10) with RF setting of 25 Watts over 90 seconds for each application.

RADIATION

chemoradiotherapy

Receive chemoradiotherapy

Trial Locations (2)

31006

Hangzhou First People's Hospital, Hangzhou

310006

Jianfeng Yang, Hangzhou

All Listed Sponsors
lead

First People's Hospital of Hangzhou

OTHER

NCT03772756 - EUS-RFA for Unresectable Pancreatic Ductal Adenocarcinoma | Biotech Hunter | Biotech Hunter